vaccinex.com (VCNX) - Volume dana dhuwit perusahaan

Simbol resmi perusahaan Vaccinex, Inc. (VCNX)

Patent protection for SEMA4D and FDA costs are creating volatility, which is reflected in the current cash balance. The value of 0.00 indicates the level of this metric. Breakthrough developments in oncology therapy provide a foundation of stability, while the talent pool of biologists guarantees the creation of next-generation innovative drugs. The liquidity dynamics on the chart confirm the ability of Vaccinex, Inc. (VCNX) to fund its scientific ambitions.

VCNX - Cadangan dhuwit perusahaan Vaccinex, Inc ing rentang 04.07.2022 - 28.12.2024

Rincian analitis perusahaan Vaccinex, Inc.

- rega saiki lan proyeksi nilai saham:
Pambiji fundamental perusahaan:Vaccinex Inc. VCNX
Produk merek Vaccinex

This metric serves as a key solvency criterion for Vaccinex, Inc. (VCNX) when assessing investment risks. The metric measures the dynamics of available cash, allowing for the determination of the balance between financial stability and capital efficiency. Analysis of the cash liquidity chart reveals the issuer's ability to cover operating expenses without resorting to external borrowing. Current resource reserves guarantee the uninterrupted operation of antibody development laboratories. The readiness of production facilities to scale molecule synthesis confirms the strategic importance of existing reserves.

Pesaing Vaccinex, Inc. (VCNX)

Dhuwit awis perusahaan IBRX (ImmunityBio Corp)|Gunggung dana dhuwit perusahaan IMCR|Volume dana dhuwit perusahaan JANX (Janux Therapeutics, Inc.)|Sisa dhuwit perusahaan RCUS|zymeworks.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Tango Therapeutics Corp|Iovance Biotherapeutics (IOVA) - Dana dhuwit perusahaan|Immatics N.V. - Sisa dhuwit perusahaan|XNCR (xencor.com) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan Compass Therapeutics Inc|Dana dhuwit perusahaan Replimune (REPL)|LYEL: Total volume dana dhuwit perusahaan|Innate Pharma SA - Dhuwit awis perusahaan|Pyxis Oncology, Inc. (PYXS) - Cadangan dhuwit perusahaan|Compugen - Volume dana dhuwit perusahaan|Aset likuid perusahaan IO Biotech Inc IOBT|STRO (Sutro Biopharma Inc.) - Dhuwit awis perusahaan|INKT - Aset likuid perusahaan|Dana dhuwit perusahaan werewolftx.com|Dhuwit awis perusahaan Immix Biopharma, Inc. (IMMX)|Dhuwit awis perusahaan ALXO (ALX Oncology Holdings)|Dana dhuwit perusahaan CUE (Cue Biopharma)|Volume dana dhuwit perusahaan PDSB (PDS Biotechnology Corp)|sonnetbio.com (SONN) - Cadangan dhuwit perusahaan|MAIA Biotechnology - Volume dana dhuwit perusahaan|LIMN - Volume dana dhuwit perusahaan|LVTX: Volume dana dhuwit perusahaan|NextCure - Sisa dhuwit perusahaan|LPTX (Leap Therapeutics Inc) - Volume dana dhuwit perusahaan|INTS (Intensity Therapeutics, Inc.) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan SNSE|Dana dhuwit perusahaan TOVX (Theriva Biologics, Inc.)|Gritstone bio, Inc. - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan Kineta KA|NexImmune Corporation - Volume dana dhuwit perusahaan|TSBX: Dana dhuwit perusahaan|Harpoon Therapeutics (HARP) - Dana dhuwit perusahaan